PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma.
Saved in:
| Title: | PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma. |
|---|---|
| Authors: | Zhao, Yaning1,2 (AUTHOR), Li, Luxi3 (AUTHOR), Jiang, Yu3 (AUTHOR), Sun, Yujiao1,2 (AUTHOR), Xu, Yi4 (AUTHOR), Ye, Xinyi3 (AUTHOR), Zhang, Fangming5 (AUTHOR), Zhu, Fenxia1,2 (AUTHOR), Pan, Yunzhi3 (AUTHOR) yunzhipan@126.com, Ma, Sai4 (AUTHOR) marseillems@outlook.com |
| Source: | Scientific Reports. 11/28/2025, Vol. 15 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20452322 |
|---|---|
| DOI: | 10.1038/s41598-025-26858-5 |
